Bronchiolitis Obliterans Syndrome Bos clinical trials

Explore recruiting bronchiolitis obliterans syndrome bos clinical trials.

Recruiting bronchiolitis obliterans syndrome bos studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bronchiolitis Obliterans Syndrome Bos trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of an anti-TSLP monoclonal antibody in the management of chronic bronchial disease induced by bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cells transplantation recipients.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Bronchiolitis Obliterans Syndrome Bos trials by city

Bronchiolitis Obliterans Syndrome Bos in Toronto Bronchiolitis Obliterans Syndrome Bos in Vancouver Bronchiolitis Obliterans Syndrome Bos in Montreal Bronchiolitis Obliterans Syndrome Bos in Calgary Bronchiolitis Obliterans Syndrome Bos in Edmonton Bronchiolitis Obliterans Syndrome Bos in Ottawa Bronchiolitis Obliterans Syndrome Bos in Winnipeg Bronchiolitis Obliterans Syndrome Bos in Quebec City Bronchiolitis Obliterans Syndrome Bos in Hamilton Bronchiolitis Obliterans Syndrome Bos in Kitchener Bronchiolitis Obliterans Syndrome Bos in London Bronchiolitis Obliterans Syndrome Bos in Halifax Bronchiolitis Obliterans Syndrome Bos in New York Bronchiolitis Obliterans Syndrome Bos in Los Angeles Bronchiolitis Obliterans Syndrome Bos in Chicago Bronchiolitis Obliterans Syndrome Bos in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease